Loading provider…
Loading provider…
Medical Oncology Physician in Boston, MA
NPI: 1447352448Primary Practice Location
MASSACHUSETTS GENERAL HOSPITAL
55 Fruit St, Boston, MA
Primary Employer
Massachusetts General Hospital
massgeneral.org
HQ Phone
Get MD Othon's Phone Numberphone_androidMobile
Get MD Othon's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 45 | 97 |
| 2 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 14 | 20 |
von Hippel-Lindau disease: genetic and clinical observations.
Authors: @ValidYN, LastName, ForeName, Initials, AffiliationInfo
Journal: Front Horm Res
Understanding the Impact of Belzutifan on Treatment Strategies for Patients with VHL.
Authors: Eric Jonasch, Neal Patel, Brian Shuch, Peter Muraki, Gennady Bratslavsky
Journal: J Kidney Cancer VHL
Publication Date: 2022-09-28
Metabolic requirements for cancer cell proliferation.
Authors: Keibler, Mark A, Wasylenko, Thomas M, Kelleher, Joanne K, Iliopoulos, Othon, Vander Heiden, Matthew G, Stephanopoulos, Gregory
Journal: Cancer Metab
Publication Date: 2016-08-18
Lead Sponsor: Calithera Biosciences, Inc
Intervention / Treatment: DRUG: CB-Cabo, DRUG: CB-839, DRUG: Pac-CB, DRUG: CBE, DRUG: CB-Erl, DRUG: CBD